Cell Harvesting Market Segmentation Detailed Study With Forecast Up To 2023

 The global cell harvesting market is expected to grow significantly over the forecast period. It is estimated that the global cell harvesting market is expected to register a CAGR of Approx. 8.75% with an estimated market value of USD 209.5 million during the forecast period from  2018 to 2023. Cell harvesting is performed by separating the cell culture from the growing medium, involving techniques such as centrifugation, microfiltration, and depth filtration.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6801

Numerous factors such as an increase in chronic infections and diseases, the rapid growth of the biotechnology and pharmaceutical industries, and rising research in regenerative medicines are expected to drive the growth of the market. Moreover, the cost-effectiveness, ease of use, the durability of harvesters, technological advancements, and design development of cell harvester devices fuel the growth of the market. Several companies are also involved in new product launches to strengthen their position in the market. For instance, in September 2018, AVITA Medical, a global regenerative medicine company, announced that the US Food and Drug Administration (FDA) approved the Company’s Premarket Approval (PMA) application to market the RECELL Autologous Cell Harvesting Device (RECELL System). This device helps to treat severe burns in patients of 18 years and older.

Key players:

ads-tec GmbH, Argos Technologies, Inc., Arthrex, Inc., Avita Medical, Bertin, connectorate, Cox Scientific, hynoDent AG, PerkinElmer Inc., Scinomix, Teleflex Incorporated, and TERUMO CORPORATION are some of the key players in the global cell harvesting market.

Intended Audience

• Pharmaceutical companies
• Biotechnology companies
• Cell harvester vendors
• Research and Development (R&D) companies
• Government research institutes
• Academic institutes and universities

However, the technical complexity of harvesters, coupled with ethical issues related to embryonic stem cell research may curb the growth of the market. Stringent government regulations and mandatory licensing rules may also hamper the market growth during the assessment period.

Market Segmentation:

The global cell harvesting market has been segmented into product type, application, and end user.

The market, on the basis of product type, has been segmented into manual cell harvesters and automated cell harvesters.

The manual cell harvesters segment is estimated to hold the largest share owing to the high preferability of manual cell harvesters, whereas the automated cell harvesters segment is expected to be the fastest growing segment due to increased awareness and rise in the use of automated technologies in devices.

The market, by application, has been segmented into biopharmaceutical application, stem cell research, and others.

The market, by end user, has been segmented into pharmaceutical companies, biotechnology companies, research institutes, and others.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the global cell harvesting market owing to a well-developed healthcare sector and growing healthcare expenditure. For instance, according to the data published by the Committee for a Responsible Federal Budget in May 2018, the US spent about USD 3.5 trillion, or 18% of its Gross Domestic Product (GDP) on health expenditures, which accounted for more than twice the average among developed countries in  2017. Additionally, many companies in this region focus on the innovation of new treatment options, thus being a lucrative option for the growth of the market in this region.

Europe is expected to hold the second largest position in the global cell harvesting market. The market growth in this region owes to the availability of funds for research. For instance, according to the data published by the National Institute of Health Funding (NIHR) in 2016, funding of EUR 928 million was announced for new NIHR Biomedical Research Centers (BRC) and NIHR Clinical Research Facilities (CRF) for five years starting from April 2017.

Asia-Pacific is anticipated to be the fastest growing region in the market due to the presence of a huge patient population and continuously developing economies.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/cell-harvesting-market-6801

Neuroprosthetics Market Expected To Boost During 2020 To 2023

 The global neuroprosthetics market was estimated USD 5.28 billion in 2016 and expected to reach USD 10.48 billion by 2023 at a CAGR of 12.4% from 2018 to 2023.

Neuroprosthetics are medical devices that are developed in such a way that provide signal to the central nervous system and receive indications from the external environment. These devices are used in neural diseases such as Epilepsy, Parkinson’s disease, Visual Prosthetics and many more.

The factors responsible for the positive growth of this market are increasing prevalence of neural diseases, over active bladder syndrome, and chronic disorder which include epilepsy.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6782

 However, factors such as, low acceptance of neuroprosthetics treatment devices due to its high cost, and low awareness about the devices may restrict the market growth during the forecast period.

Segmentation:

The global neuroprosthetics market is segmented on the basis of type, technology, applications, and end users. On the basis of type the market is segmented into output neural prosthetics and input neural prosthetics. The output is segmented into cognitive prosthetics, and motor prosthetics. The input is segmented into cochlear implant, and visual prosthetic.

 On the basis of techniques, the market is segmented into vagus nerve stimulation, deep brain stimulation, sacral nerve stimulation, and spinal cord stimulation.

On the basis of application, the market is segmented into motor neuron disorders, physiological disorders, and cognitive disorders. The motor neuron disorders are segmented into Parkinson’s disease, and Epilepsy disorder. The physiological disorders are segmented into auditory processing disorders, ophthalmic disorders, cardiovascular disorders, and urology disorders. Furthermore, the cognitive disorders include disorders such as Alzheimer’s disease, paralysis, and severe depression. On the basis of end-users, the market is segmented into hospitals and clinics, diagnostic centers, research centers and others.

On the basis of region, the global Neuroprosthetics market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.

Key players:

Some of the key players in the global neuroprosthetics market are Medtronic (US), Abbott (US), Cochlear (Australia), Boston Scientific (US), Livanova (UK), Second Sight (US), Med-El (UK), Retina Implant (US), Sonova (UK), Neuropace (US), Nevro (California), and others. 

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/neuroprosthetics-market-6782

Latest Study Offers Detailed Insights On Bioburden Testing Market 2023

 Global Bioburden Testing Market is expected to grow significantly over the forecast period. It is estimated that the global bioburden testing market is expected to register a CAGR of Approx. 9.15% during the forecast period of 2018–2023 with an estimated market value of USD 455 million. Bioburden testing refers to an estimation of microbial load on a medical instrument, raw material, packaged goods among others. Bioburden testing is carried out to ascertain if the types and numbers of micro-organisms present are satisfactory or unsatisfactory when compared to predefined acceptance criteria.

Several factors such as increasing food safety concerns, rising medical spending, growing product recalls due to microbial contamination are expected to drive the growth of the market. The major players are involved in strategic collaborations and new product launches to strengthen their position in the market. For instance, in October 2018, SGS SA acquired IBR Inc., a non-clinical contract research organization (CRO). IBR Inc. focuses on integral services in biopharmaceutical analytics for the development of biologics, biosimilars and vaccines, and provides several filter testing and particle counting services. 

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6716

However, high costs of microbial enumeration instruments and complex and time-consuming regulatory standards in some economies may hinder the market growth during the assessment period. Also, test reports and certificates tend to be different from one country to another which hampers international trade. Therefore, in December 2017, International Organization for Standardization (ISO) published a new edition of ISO/IEC 17025 standard. This standard is an international reference for laboratories carrying out calibration and testing activities around the world. ISO/IEC 17025 helps facilitate cooperation between laboratories and other bodies by generating wider acceptance of results between countries.

Segmentation:

The global bioburden testing market has been segmented into test type, product type, application and end-user.

The market, on the basis of type, has been segmented into aerobic count, anaerobic count, fungi count and spore count.

The market, on the basis of product type, has been segmented into consumables and instruments.

The market, by consumables, has been sub-segmented into reagents and kits, and others.

The market, by instruments, has been further segmented into polymerase chain reaction machine (PCR), microscopes, and others.

The market, by application, has been segmented into raw materials testing, medical devices testing, in-process material testing, sterilization validation testing, and equipment cleaning validation.

The market, by end-user, has been segmented into pharmaceutical and biotechnology companies, microbial testing laboratories, and others.

The market, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The bioburden testing market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European bioburden testing market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The bioburden testing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Bioburden Testing market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players:

Charles River, SGS SA, WuXi AppTec, Merck KGaA, NORTH AMERICAN SCIENCE ASSOCIATES INC., Becton, Dickinson, and Company, Nelson Laboratories, LLC, Pacific Biolabs, ATS Laboratories, Inc., and Dynatec Labs are some of the major players in the global bioburden testing market.

Geographically, the Americas is anticipated to dominate the global bioburden testing market owing to a well-developed healthcare infrastructure, and growing healthcare expenditure. Moreover, favourable reimbursement scenario in this region fuels the growth of the market.

Europe is expected to hold the second largest position in the global bioburden testing market. The market growth in this region is attributed to the availability of funds for research.

Asia-Pacific is anticipated to be the fastest growing region in the market due to the presence of a huge patient population, continuously developing economies, and increasing government funding for healthcare sector. Also, there is a strong presence of major players in this region which boosts the market growth.

On the other hand, the Middle East and Africa has the least share of the market. Majority of the market share of this region is expected to be held by the Middle East region due to the growing government initiatives for the healthcare sector.

Browse More Details of the Report @  https://www.marketresearchfuture.com/reports/bioburden-testing-market-6716

Worldwide Hemiplegic Migraine Market Ready To Set Outstanding Growth From 2020 To 2023

 Hemiplegic migraine, although a rare type of migraine its symptoms are almost same as other migraines.  Intense and throbbing pain, nausea, and sensitivity to light and sound are some of the symptoms caused by hemiplegic migraine. “Hemiplegia” means paralysis and people suffering from it literally feel temporary symptoms of paralysis such as temporary weakness, numbness and tingling, and paralysis on one side of the body which start before the headache.

Although the hemiplegic migraine is considered as a rare disorder affecting a small number of people, over the past few years, the prevalence of hemiplegic migraine has been increasing. Out of the two types of hemiplegic migraine, familial hemiplegic migraine (FHM) is a hereditary condition that affects at least two close relatives in the same family.  

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6713

Whereas, the other type, sporadic hemiplegic migraine (SHM) can affect anyone even those who don’t have any family history of the condition. Factors such as changing lifestyle, environmental changes, pollutions, etc. are causes behind the occurrence of SHM. As a result, sporadic hemiplegic migraine is more prevalent than FHM.

However, there are a number of treatment methods available to treat both the types of hemiplegic migraines owing to the technological advancements that happened in the field of medical science in the recent years. Growing prevalence and the availability of treatments are the two key driving forces behind the market growth of hemiplegic migraines.

Considering all these factors, the global market of the hemiplegic migraine is expected to reach approximately 1008 MN USD by the end of 2023, growing at a CAGR of approximately 3.3% during the forecast period (2018-2023). In 2017, the market had valued at USD 830 Million.

Segments

The global hemiplegic migraine market has been segmented on the basis of type, treatment, preventive treatment, distribution channel, end-user, and region. By type, the market is segmented into familial hemiplegic migraine and sporadic hemiplegic migraine. By end-user, the market is segmented into hospitals & clinics, diagnostic centers, and others.

By treatment, the market is segmented into acute treatment, triptans, ergotamines, nsaids, antiemetics, narcotic analgesics, and others. By preventive treatment, the market is segmented into antidepressants, botox injections, and others. By distribution channel, the market is segmented into retail pharmacies, hospital pharmacies, online pharmacies, and others. By region, the market is segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa.

Regional analysis

The Americas accounts for the leading market due to the higher health care expenditures. The fastest uptake of new technologies in the growing healthcare sector is a major driving force driving the market. The presence of well-established market players is fuelling the market.

The market in the European region stands at the second position in terms of the market size owing to the well-established healthcare sector. Also, high per capita healthcare expenditures play a vital role in the market growth.

Whereas, the Asia Pacific region is expected to grow rapidly due to the emerging economies such as China and India.

In Gulf nations, particularly, Saudi Arabia and UAE drive the Middle Eastern & African market. The African region is estimated to witness moderate growth owing to poor economic & political conditions and inadequate healthcare facilities.

Key Players

Some of the market leaders profiled in the report are Abbott Laboratories, Allergan Plc., AstraZeneca, Eisai Co., Ltd., Endo International Plc., GlaxoSmithKline Plc., Impax Laboratories, Eli Lily and Company, Johnson & Johnson, and Merck & Co.

Research Methodology

The research report – Global Hemiplegic Migraine Market by Market Research Future comprises an in-depth primary research and the detailed analysis of qualitative as well as quantitative aspects of various industry experts. The detailed market analysis gives a clear picture of the current market scenarios including past and future market size in terms of value as well as volume alongside the technological advancement, macroeconomy, and governing factors of the market. The report provides detailed information and strategies of topnotch players in the market while providing a broad study of the market and its various segments in the outlined regions.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/hemiplegic-migraine-market-6713

Global Nuclear Medicine Market 2020 Analysis By Manufacturers, Latest Trends, Competitive Landscape And Strategies

 Market Research Future (MRFR)’s report highlights that the global nuclear medicine market is likely to strike a CAGR of 6.2% during the forecast period 2018 to 2023. The valuation of the market is expected to witness a growth of USD 5.430 Bn by the end of 2023. The growth of the market is dictated by increasing incidences of target conditions such as Cardiovascular Diseases (CVD) and cancer. Furthermore, the exponentially growing geriatric population is poised to add to the patient pool. The rising inclination towards the use of radiopharmaceuticals for the treatment of geriatric population is prognosticated to generate significant demand for nuclear medicines in the foreseeable future.

The market looks lucrative and is expanding at a significant pace. It is anticipated to witness constant growth over the next couple of years owing to increasing applications, discoveries, etc. Nevertheless, the expensiveness of the radiopharmaceuticals and side effects related to radiation exposure remain impediments to the market proliferation.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6674

Report Coverage:

The report covers an in-depth study of the historical trends, current market status, forecast, and key players’ market share analysis. It also encompasses market factor analysis which includes supply chain analysis and Porter’s five forces analysis. The market is analyzed in detail by region as well as segmentation, and, a country-level analysis for each segment is also available in the report.

Report Overview:

This MRFR’s report offers a detailed five-year forecast (2018 to 2023) for the global nuclear medicine market. It reflects a revenue analysis of the different product types, including diagnostic nuclear medicine and therapeutic radiopharmaceuticals. The major applications discussed in the study encompasses diagnostic applications and therapeutic applications. The report also presents a detailed analysis of the end-users such as hospitals & diagnostic centers, research institutes, and others. A regional assessment of the market is published in the report for enhanced lucidity, which covers Americas, Europe, Asia Pacific, and the Middle East & Africa.

Companies Covered:

Some of the key players operating in the market are Cardinal Health, GE Healthcare, Bayer, Bracco Imaging, Curium, Lantheus Medical Imaging, Nordion Inc., Advanced Accelerators Applications, Mallinckrodt Pharmaceuticals, Jubliant Lifesciences, and Medtronic plc.

Research Methodology:

MRFR strives to leverage its industry expertise for offering insightful conclusions into the market that reflects the latest trends and foresight. Analytical algorithms are utilized for assessing and challenging the data curated through extensive primary and secondary research. The credible sources referred for data collection include interviews, SEC filings, whitepaper references, paid database services, etc. A multi-layer verification process authenticates the premium quality and reliability of the statistical observations offered in the report. Additionally, top-down and bottom-up approaches are employed for re-validating the accuracy of the quantitative assessment of the market.

Market Segmentation

MRFR has conducted a detailed study of the various parts of the nuclear medicine market which has been segmented on the basis of product type, application, end-user, and region. By product types, the nuclear medicine market has been segmented into diagnostic nuclear medicine and therapeutic radiopharmaceuticals. At present, the diagnostic nuclear medicine segment has attained a leadership position. However, the therapeutic radiopharmaceuticals segment is the fastest growing segment during the forecast period. The diagnostic nuclear medicine segment is segmented further into SPECT radiopharmaceuticals, and PET radiopharmaceuticals. Meanwhile, the therapeutic radiopharmaceuticals segment is sub-segmented into alpha emitters, beta emitters, and brachytherapy isotopes.

Applications of nuclear medicine are segmented into diagnostic applications and therapeutic applications. Diagnostic applications is a major segment which is sub-segmented into SPECT applications and PET applications. Meanwhile, the therapeutic applications segment is growing at the fastest pace.

End-users have been segmented into hospitals & diagnostic centers, research institutes, and others. Research institutes display the highest potential for growth over the forecast period, while hospitals & diagnostics centers have been identified as the most significant segment in terms of market share.

All sub-segments have been segmented further and included in the report.

Regional Analysis

The Americas due to the presence of North America has established itself as a market leader. The presence of several important market players combined with the high prevalence of cancer and other chronic diseases has influenced the growth of the Americas nuclear market. The region, particularly countries such as U.S & Canada have well-developed healthcare sectors which receive high investments. Moreover, the region has a high geriatric patient population which is expanding rapidly and is growing increasingly aware regarding advanced therapies.

Browse More Details of the Report @  https://www.marketresearchfuture.com/reports/nuclear-medicine-market-6674

Medical Device Security Market 2020 - Shares, Revenue, Analysis And Forecasts Till 2023

 Market Research Future (MRFR)’s report reveals that the global medical device security market is set to expand at a CAGR of 8.8% during the forecast period 2018 to 2023. The valuation of the global market is estimated to witness a growth of USD 221 Mn over the review period. The developments in the healthcare sector have catalyzed the deployment of medical facilities systems. These devices are prone to hacking and pose a threat to the critical data related to healthcare centers and the privacy of the patients. Additionally, the rising cases of cyber-attacks have further intensified the security concern in the recent times. This trend is expected to create demand for medical device security solutions over the next couple of years.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6650

Rapid adoption of connected medical devices in the healthcare sector of developed and developing regions has increased the concerns regarding theft of personal medical data. Rise in incidences of cybercrime and misuse of personal data is inducing high demand for advanced medical device security modules, leading to the significant expansion of the global medical device security market. However, low penetration of technologically advanced medical devices, lack of awareness regarding the availability of advanced healthcare data security solutions and low healthcare budgets are likely to act as restraints on the expansion of the global medical device security market during the forecast period.

Market Segmentation:

The Global Medical Device Security Market has been segmented on the basis of component, type and end user. Based on component, the medical device security market has been segmented into solutions and services. The solutions segment has been sub-segmented into identity & access management solutions, antivirus/ antimalware solutions, encryption solutions, data loss prevention solutions, risk & compliance management, intrusion detection system/ intrusion prevention systems, disaster recovery solutions, distributed denial of service solutions and others. The services segment has been sub-segmented into professional services and managed security services. The professional services sub-segment includes consulting services, training & education, support & maintenance and design & integration. The solutions segment commands for the major share in the global medical device security market.

Based on type, the medical device security market has been segmented into network security, endpoint security, application security, cloud security and others. The endpoint security segment commands for the lion’s share in the global medical device security market. Based on end user, the medical device security market has been segmented into healthcare providers, medical device manufacturers and healthcare players. the healthcare providers segment commands for a dominant share in the global medical device security market.

Regional Analysis:

Geographically, the global medical device security market has been segmented into four major regions such as Europe, Americas, Asia Pacific and the Middle East and Africa. The Americas command for the major share in the global medical device security market owing to the presence of large number of players that are providing healthcare industry with advanced security solutions, rapid adoption of internet of things and higher threat of cyber-attacks in this region. The Europe region is projecting noteworthy growth in the global medical device security market owing to the increased incidences of cybercrime, rise in utilization of advanced connected medical devices and increased research and development expenditure for introducing highly effective security solutions in the healthcare sector in this region.

The Asia Pacific region is projecting significant expansion at the fastest growth rate in the global medical device security market owing to the increasing usage of connected medical devices that are operating with the help of healthcare IoT and rise in concern regarding data security in the healthcare sector of developing economies in this region. The Middle East and Africa region is expanding at a slow growth rate in the global medical device security market owing to the low penetration of advanced technology in the healthcare sector of the underdeveloped areas of this region.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/medical-device-security-market-6650 

Bowel Management Systems Market Worldwide Key Players Forecasts By Revenue, Growth Rate Till 2023

 Rapid change in lifestyles and unhealthy dietary habits is leading to the rise in intestinal issues such as fecal incontinence and constipation among adults. With advancement in healthcare technology and development of various medical devices, these health issues are being managed with the help of bowel management systems.

Market Research Future (MRFR) has published a report asserting that the global bowel management systems market is marked to expand steadily at a CAGR of 4.1% during the forecast period of 2017-2023 and reach the valuation of 2.188 Bn by the end of 2023 from 1.72 Bn in 2017.
Global rise in geriatric population and dietary imbalance caused due to consumption of unhealthy food are majorly propelling the growth of the global bowel management systems market. However, concerns regarding the discomfort associated with the use of bowel management devices and inclination towards adoption of non-invasive treatments are likely to restrain the growth of the global bowel management systems market during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6649

Companies Covered

The leading players operating in the global bowel management systems market are Coloplast (Denmark), Medtronic (Ireland), 3M (the U.S.), B. Braun (Germany), C.R. Bard (the U.S.), Consure Medical (India), Cogentix Medical (the U.S.), Aquaflush Medical Limited (the U.K.), Axonics Modulation Technologies (the U.S.), ConvaTec (the U.K.), Hollister (the U.S.), MBH-International A/S (Denmark), Mederi Therapeutics Inc. (the U.S.), Welland Medical limited (the U.K.), and Wellspect HealthCare (Sweden).

Market Segmental Analysis

For scope of the report, MRFR offers a comprehensive segmental analysis of the global bowel management systems market

By Product

• Irrigation Systems 
• Colostomy Bags
• Nerve Modulation Devices (NMD)
• Other Products and Accessories

By Patient Type

• Adult Patients
• Pediatric Patients

By End User

• Home Care
• Hospitals & Ambulatory Surgery Centers

By Region

• Americas
• Europe
• Asia-Pacific
• Middle East and Africa

Report Overview

The MRFR’s market research report offers an unbiased and comprehensive assessment of key market dynamics in the global bowel management systems market. It includes discussion on current and historical market trends, challenges and growth opportunities backed by factful feedbacks. The primary types of products that are covered in the report are irrigation systems, colostomy bags, nerve modulation devices (NMD) and other products and accessories. The types of patients covered in the report are adult patients and pediatric patients. For opportunity analysis, the major end-users covered in the report are home care and hospitals and ambulatory surgery centers. All the sub-markets included in the report are profiled under four major regions such as Europe, Asia Pacific, Americas and the Middle East and Africa, with respective country-level analysis.

Research Methodology

Market Research Future (MRFR) leverages its comprehensive and iterative research methodology for the deliverance of highly accurate market insights. The primary and secondary research processes are utilized for conducting qualitative and quantitative analysis of current and historical market dynamics, consumer landscape, competitive landscape, market growth opportunities and challenges. Detailed surveys and first-hand interviews are conducted with the key opinion makers across the value chain for the collection of primary data. Secondary research processes are utilized for primary data validation through inputs from SEC filings, white paper references, paid databases, research publications and other credible sources available in public domain. The data triangulation techniques and top-down and bottom-up approaches are utilized to ensure accuracy and objectivity of the research findings.

Browse More Details of the Report @  https://www.marketresearchfuture.com/reports/bowel-management-systems-market-6649